0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemophilia Treatment Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-3J6348
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Hemophilia Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hemophilia Treatment Market Research Report 2024

Code: QYRE-Auto-3J6348
Report
May 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemophilia Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hemophilia Treatment Market

Hemophilia Treatment Market

Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological advancements are driving the growth of this market. Lack of available medicines, awareness of this disease and high cost of treatment are the major restraining factors in this market. The advancements in gene Therapy and approaching approval of drugs for treatment of hemophilia provide growth opportunities in this market.
The global Hemophilia Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hemophilia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemophilia Treatment.

Report Scope

The Hemophilia Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemophilia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemophilia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hemophilia Treatment Market Report

Report Metric Details
Report Name Hemophilia Treatment Market
CAGR 5%
Segment by Type
  • On-demand
  • Prophylaxis
Segment by Application
  • Replacement Therapy
  • ITI Therapy
  • Gene Therapy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen, Novo Nordisk, Roche, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hemophilia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hemophilia Treatment Market report?

Ans: The main players in the Hemophilia Treatment Market are CSL Behring, Baxalta, Pfizer Inc, BioMarin, Bayer Healthcare, Biogen, Novo Nordisk, Roche, Takeda

What are the Application segmentation covered in the Hemophilia Treatment Market report?

Ans: The Applications covered in the Hemophilia Treatment Market report are Replacement Therapy, ITI Therapy, Gene Therapy

What are the Type segmentation covered in the Hemophilia Treatment Market report?

Ans: The Types covered in the Hemophilia Treatment Market report are On-demand, Prophylaxis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 On-demand
1.2.3 Prophylaxis
1.3 Market by Application
1.3.1 Global Hemophilia Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Replacement Therapy
1.3.3 ITI Therapy
1.3.4 Gene Therapy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia Treatment Market Perspective (2019-2030)
2.2 Hemophilia Treatment Growth Trends by Region
2.2.1 Global Hemophilia Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemophilia Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hemophilia Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hemophilia Treatment Market Dynamics
2.3.1 Hemophilia Treatment Industry Trends
2.3.2 Hemophilia Treatment Market Drivers
2.3.3 Hemophilia Treatment Market Challenges
2.3.4 Hemophilia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemophilia Treatment Players by Revenue
3.1.1 Global Top Hemophilia Treatment Players by Revenue (2019-2024)
3.1.2 Global Hemophilia Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemophilia Treatment Revenue
3.4 Global Hemophilia Treatment Market Concentration Ratio
3.4.1 Global Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Treatment Revenue in 2023
3.5 Hemophilia Treatment Key Players Head office and Area Served
3.6 Key Players Hemophilia Treatment Product Solution and Service
3.7 Date of Enter into Hemophilia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Treatment Breakdown Data by Type
4.1 Global Hemophilia Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hemophilia Treatment Forecasted Market Size by Type (2025-2030)
5 Hemophilia Treatment Breakdown Data by Application
5.1 Global Hemophilia Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hemophilia Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemophilia Treatment Market Size (2019-2030)
6.2 North America Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemophilia Treatment Market Size by Country (2019-2024)
6.4 North America Hemophilia Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemophilia Treatment Market Size (2019-2030)
7.2 Europe Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemophilia Treatment Market Size by Country (2019-2024)
7.4 Europe Hemophilia Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemophilia Treatment Market Size (2019-2030)
8.2 Asia-Pacific Hemophilia Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemophilia Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemophilia Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemophilia Treatment Market Size (2019-2030)
9.2 Latin America Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemophilia Treatment Market Size by Country (2019-2024)
9.4 Latin America Hemophilia Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemophilia Treatment Market Size (2019-2030)
10.2 Middle East & Africa Hemophilia Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemophilia Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemophilia Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Detail
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Hemophilia Treatment Introduction
11.1.4 CSL Behring Revenue in Hemophilia Treatment Business (2019-2024)
11.1.5 CSL Behring Recent Development
11.2 Baxalta
11.2.1 Baxalta Company Detail
11.2.2 Baxalta Business Overview
11.2.3 Baxalta Hemophilia Treatment Introduction
11.2.4 Baxalta Revenue in Hemophilia Treatment Business (2019-2024)
11.2.5 Baxalta Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Detail
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Hemophilia Treatment Introduction
11.3.4 Pfizer Inc Revenue in Hemophilia Treatment Business (2019-2024)
11.3.5 Pfizer Inc Recent Development
11.4 BioMarin
11.4.1 BioMarin Company Detail
11.4.2 BioMarin Business Overview
11.4.3 BioMarin Hemophilia Treatment Introduction
11.4.4 BioMarin Revenue in Hemophilia Treatment Business (2019-2024)
11.4.5 BioMarin Recent Development
11.5 Bayer Healthcare
11.5.1 Bayer Healthcare Company Detail
11.5.2 Bayer Healthcare Business Overview
11.5.3 Bayer Healthcare Hemophilia Treatment Introduction
11.5.4 Bayer Healthcare Revenue in Hemophilia Treatment Business (2019-2024)
11.5.5 Bayer Healthcare Recent Development
11.6 Biogen
11.6.1 Biogen Company Detail
11.6.2 Biogen Business Overview
11.6.3 Biogen Hemophilia Treatment Introduction
11.6.4 Biogen Revenue in Hemophilia Treatment Business (2019-2024)
11.6.5 Biogen Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Hemophilia Treatment Introduction
11.7.4 Novo Nordisk Revenue in Hemophilia Treatment Business (2019-2024)
11.7.5 Novo Nordisk Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Hemophilia Treatment Introduction
11.8.4 Roche Revenue in Hemophilia Treatment Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Takeda
11.9.1 Takeda Company Detail
11.9.2 Takeda Business Overview
11.9.3 Takeda Hemophilia Treatment Introduction
11.9.4 Takeda Revenue in Hemophilia Treatment Business (2019-2024)
11.9.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Hemophilia Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of On-demand
    Table 3. Key Players of Prophylaxis
    Table 4. Global Hemophilia Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Hemophilia Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Hemophilia Treatment Market Share by Region (2019-2024)
    Table 8. Global Hemophilia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Hemophilia Treatment Market Share by Region (2025-2030)
    Table 10. Hemophilia Treatment Market Trends
    Table 11. Hemophilia Treatment Market Drivers
    Table 12. Hemophilia Treatment Market Challenges
    Table 13. Hemophilia Treatment Market Restraints
    Table 14. Global Hemophilia Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Hemophilia Treatment Market Share by Players (2019-2024)
    Table 16. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Treatment as of 2023)
    Table 17. Ranking of Global Top Hemophilia Treatment Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Hemophilia Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Hemophilia Treatment Product Solution and Service
    Table 21. Date of Enter into Hemophilia Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Hemophilia Treatment Revenue Market Share by Type (2019-2024)
    Table 25. Global Hemophilia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Hemophilia Treatment Revenue Market Share by Type (2025-2030)
    Table 27. Global Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Hemophilia Treatment Revenue Market Share by Application (2019-2024)
    Table 29. Global Hemophilia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Hemophilia Treatment Revenue Market Share by Application (2025-2030)
    Table 31. North America Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Hemophilia Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Hemophilia Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Hemophilia Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 46. CSL Behring Company Detail
    Table 47. CSL Behring Business Overview
    Table 48. CSL Behring Hemophilia Treatment Product
    Table 49. CSL Behring Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 50. CSL Behring Recent Development
    Table 51. Baxalta Company Detail
    Table 52. Baxalta Business Overview
    Table 53. Baxalta Hemophilia Treatment Product
    Table 54. Baxalta Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 55. Baxalta Recent Development
    Table 56. Pfizer Inc Company Detail
    Table 57. Pfizer Inc Business Overview
    Table 58. Pfizer Inc Hemophilia Treatment Product
    Table 59. Pfizer Inc Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 60. Pfizer Inc Recent Development
    Table 61. BioMarin Company Detail
    Table 62. BioMarin Business Overview
    Table 63. BioMarin Hemophilia Treatment Product
    Table 64. BioMarin Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 65. BioMarin Recent Development
    Table 66. Bayer Healthcare Company Detail
    Table 67. Bayer Healthcare Business Overview
    Table 68. Bayer Healthcare Hemophilia Treatment Product
    Table 69. Bayer Healthcare Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 70. Bayer Healthcare Recent Development
    Table 71. Biogen Company Detail
    Table 72. Biogen Business Overview
    Table 73. Biogen Hemophilia Treatment Product
    Table 74. Biogen Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 75. Biogen Recent Development
    Table 76. Novo Nordisk Company Detail
    Table 77. Novo Nordisk Business Overview
    Table 78. Novo Nordisk Hemophilia Treatment Product
    Table 79. Novo Nordisk Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 80. Novo Nordisk Recent Development
    Table 81. Roche Company Detail
    Table 82. Roche Business Overview
    Table 83. Roche Hemophilia Treatment Product
    Table 84. Roche Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 85. Roche Recent Development
    Table 86. Takeda Company Detail
    Table 87. Takeda Business Overview
    Table 88. Takeda Hemophilia Treatment Product
    Table 89. Takeda Revenue in Hemophilia Treatment Business (2019-2024) & (US$ Million)
    Table 90. Takeda Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hemophilia Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Hemophilia Treatment Market Share by Type: 2023 VS 2030
    Figure 3. On-demand Features
    Figure 4. Prophylaxis Features
    Figure 5. Global Hemophilia Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Hemophilia Treatment Market Share by Application: 2023 VS 2030
    Figure 7. Replacement Therapy Case Studies
    Figure 8. ITI Therapy Case Studies
    Figure 9. Gene Therapy Case Studies
    Figure 10. Hemophilia Treatment Report Years Considered
    Figure 11. Global Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Hemophilia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Hemophilia Treatment Market Share by Region: 2023 VS 2030
    Figure 14. Global Hemophilia Treatment Market Share by Players in 2023
    Figure 15. Global Top Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Treatment as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Hemophilia Treatment Revenue in 2023
    Figure 17. North America Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Hemophilia Treatment Market Share by Country (2019-2030)
    Figure 19. United States Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Hemophilia Treatment Market Share by Country (2019-2030)
    Figure 23. Germany Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Hemophilia Treatment Market Share by Region (2019-2030)
    Figure 31. China Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Hemophilia Treatment Market Share by Country (2019-2030)
    Figure 39. Mexico Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Hemophilia Treatment Market Share by Country (2019-2030)
    Figure 43. Turkey Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. CSL Behring Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 46. Baxalta Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 47. Pfizer Inc Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 48. BioMarin Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 49. Bayer Healthcare Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 50. Biogen Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 51. Novo Nordisk Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 52. Roche Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 53. Takeda Revenue Growth Rate in Hemophilia Treatment Business (2019-2024)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Oculopharyngeal Muscular Dystrophy (OPMD) Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20M15561
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Genetic Disease Diagnosis Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11V13013
Wed Jun 12 00:00:00 UTC 2024

Add to Cart

Global Sickle Cell Anemia Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-26Q12719
Fri May 24 00:00:00 UTC 2024

Add to Cart

Global Duchenne Muscular Dystrophy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-12K736
Fri May 24 00:00:00 UTC 2024

Add to Cart